Jazz Purchase of GW Pharma being Investigated by the LawyersAs is typical with any big deal the lawyers are chasing the GW Pharma purchase by Jazz for their 2.5% in legal fees.
NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating GW Pharmaceuticals plc ("GWPH" or the "Company") (GWPH) relating to its proposed acquisition by Jazz Pharmaceuticals Public Limited Company. Under the terms of the agreement, GWPH shareholders are expected to receive $200.00 in cash and $20.00 worth of Jazz ordinary shares per GWPH share they own.
Monteverde & Associates PC Logo The investigation focuses on whether GW Pharmaceuticals plc and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the proposed transaction undervalues the company.